Protect Pharmaceutical (Protect Pharmaceutical) Net Income From Continuing Operations : $-0.02 Mil (TTM As of Jun. 2018)

View and export this data going back to 2006. Start your Free Trial

What is Protect Pharmaceutical Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Protect Pharmaceutical's net income from continuing operations for the three months ended in Jun. 2018 was $-0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.02 Mil.

Protect Pharmaceutical Net Income From Continuing Operations Historical Data

The historical data trend for Protect Pharmaceutical's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protect Pharmaceutical Net Income From Continuing Operations Chart

Protect Pharmaceutical Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Net Income From Continuing Operations

Get a 7-Day Free Trial

-0.02

0.46

-0.64

-0.04

-0.12

Protect Pharmaceutical Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.10	-	-	-	-

Protect Pharmaceutical Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

Protect Pharmaceutical (Protect Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Protect Pharmaceutical Corp (OTCPK:PRTT) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

12465 South Street, Suite 240, Draper, UT, USA, 84020

Website

https://www.inaiapp.com

Protect Pharmaceutical Corp has an organic solution to soil and crop protection, annual growth, and natural restoration upon the completion of crop cycles. The company uses its products to revitalize farming soil, produce organic, toxin-free crops, and meet the increasing global demand for agricultural sustainability initiatives.